PVC Risk Management Planning 2

Question 1

Which ICH guideline specifically addresses the development and implementation of Risk Management Plans (RMPs)?

Accepted Answer

ICH E2E

Answer

ICH E2E (Pharmacovigilance Planning) provides guidance on pharmacovigilance planning including the development of RMPs.

Question 2

What is the primary purpose of a Pharmacovigilance System Master File (PSMF) in relation to risk management?

Accepted Answer

To describe the pharmacovigilance system and demonstrate its adequacy

Answer

The PSMF describes the pharmacovigilance system used by the MAH and demonstrates it meets regulatory requirements, supporting overall risk management.

Question 3

In an EU Risk Management Plan, which module specifically addresses the 'missing information' category of safety concerns?

Accepted Answer

Module SI — Safety Specification

Answer

Module SI of the EU RMP Safety Specification includes the 'Missing Information' section that identifies gaps in safety knowledge.

Question 4

A company identifies a new signal for a product already on the market. Which action within risk management planning is MOST immediately required?

Accepted Answer

Evaluate the signal and determine if RMP update is warranted

Answer

Signal evaluation is required first; if the signal is validated and changes the benefit-risk profile, the RMP must be updated accordingly.

Question 5

What distinguishes an 'important identified risk' from an 'important potential risk' in pharmacovigilance?

Accepted Answer

Identified risks have sufficient evidence of a causal association; potential risks have limited evidence

Answer

Important identified risks have established evidence of causal association, while important potential risks are suspected but lack conclusive evidence.

(PVC) Pharmacovigilance Certification Practice Test

(PVC) Pharmacovigilance Certification Practice Test

PVC Risk Management Planning 2